Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2025-12-25 @ 3:02 AM
NCT ID:
NCT02841033
Brief Title:
Daratumumab for the Treatment of Patients With AL Amyloidosis
Official Title:
A Phase I-II Trial of Daratumumab for the Treatment of Patients With AL Amyloidosis
Study:
NCT02841033
Protocol Section:
NCT02841033